Navigation Links
Bill Gates Takes Personal Interest in AIDS Program

Bill Gates, Chief of Microsoft, will visit India on 6 December 2005, along with his wife Melinda. Chennai and Bangalore will be among the cities he will visit as he reviews the progress of his $200 million HIV/AIDS initiative in India//.

India figures very high on the priority list of Microsoft. Gates' fourth visit in two years will see him sharing his IT vision as he interacts with key government officials in addition to business leaders, academicians, industry associations and policy makers.

The visit will focus further on realizing India's IT potential," said Ravi Venkatesan, chairperson of Microsoft India.

The visit will coincide with a two-day meeting of Microsoft Government Leaders Forum here. The summit, Leading in a Connected World, will bring together government leaders from across the Asian Region to discuss and exchange experiences related to economic development, governance and education.

It would examine the role IT and communication play in achieving success in these areas.

"India is very high on Microsoft's priorities. Equally important to us is our effort towards enabling India's growth as an economic superpower. We have made tremendous efforts in the past few years towards this," Venkatesan said.

Gates will deliver the closing address at the summit, according to Microsoft India. He is also scheduled to visit Bangalore and Chennai to meet some top Microsoft clients.

The scheduled Chennai visit, if it doesn't get cancelled because of floods, will also see him interact with government and NGOs to review the progress on efforts to curb the spread of HIV/AIDS.

"Microsoft India is not just the fastest growing subsidiary for Microsoft, but it is one of the few subsidiaries where it has an end to end presence of its entire business portfolio," said Venkatesan.

The public engagements of Gates include a Confederation of Indian Industry (CII) hosted CEO Forum h
'"/>




Page: 1 2

Related medicine news :

1. Bill Gates to Fund ￡28m for Malaria researc
2. Dr.Tadataka Yamada Designated to open Gates for Global Health Program
3. Gates Foundation to donate USD 104 million to TB Alliance
4. Bill Gates Clarifies that his Decision to Focus on Charity was Personal
5. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
6. Gates Foundation Adopts Fight against Encephalitis
7. Clinton, Gates Highlight Treatment, Discrimination of AIDS
8. $68 million aid pours in from Gates Foundation to fight tropical diseases
9. Gates Foundation Grants $23mn for AIDS programme in India
10. Bill Gates pours in funds for diarrhea treatment reseach
11. Gates Foundation Pledges $3 Million to Fight Malaria in Africa
Post Your Comments:
(Date:7/23/2008)...of vaccines for Immigration and Naturalization rea...lth, BALTIMORE, July 23 /PRNewswire/ -- New vacci... for an immigrant visa for entry into the U.S. and... residence. Applicants,must show proof of vaccinat...mmended by the U.S. Advisory Committee on Immuniza...
(Date:7/23/2008)...varicose veins in scrotum boosts sperm count, moti...(HealthDay News) -- A simple, minimally invasive p...ity and improve a couple,s chances of having a bab...aricocele, is a network of tangled blood vessels i...n of blood through the veins in the testicles. A m...
(Date:7/23/2008)...ELES, July 23 /PRNewswire/ -- Times may be tough, ...finding there,s nothing like,a dazzling new smile ...Kosdon, DDS helps his celebrity clients beam in on...mile brings with it the self-confidence they,need ...now sporting a new,high-wattage smile designed by ...
(Date:7/23/2008)... found the longer person had heart trouble, the wo...y 23 (HealthDay News) -- Men and women suffering f...easures of cognitive function. , And the longer...erformance in such mental processes as reasoning, ...y in the July 23 issue of the European Heart Jour...
Breaking Medicine News(10 mins):Health News:USCIS Tightens Vaccination Requirements 2Health News:Simple Procedure Improves Male Fertility 2Health News:Simple Procedure Improves Male Fertility 3Health News:Rock The Cradle's Bad Boy Landon Brown Owes His Irresistible New Smile to Dr. Michael Kosdon 2Health News:Coronary Disease Dulls Cognitive Skills 2
...ndia may have escaped from the Bird Flu epidemic t...ly. It is known that migratory birds are carrying ...-headed geese’ usually migrate to India in winter ...rus strain H5N1 that can kill human beings. So far...
...ietic-cell transplantation with the use of conditi...chemotherapy, or both to decrease early toxic effe.../ transplantation to patients older than 50 years ...owever, acute graft-versus-host disease (GVHD) rem...
...n ingredient of turmeric that gives curry its must...curcuma longa plant, curcumin is a member of the g...al medicine, it is widely prescribed in Indian med...ders, rheumatism, diabetic wounds, runny nose, cou...
...ciation (IOA) and UNICEF would collaborate on spre...tection of HIV virus. The collaboration would help...f HIV infection//. The program would enhance natio...’s and young people are more attracted towards spo...
Other Medicine News:Health News:Protective regimen for acute Graft-versus-host disease 2Health News:Curcumin found to halt spread of breast cancer in mice 2Health News:Indian Olympic Association And UNICEF To Collaborate On HIV/AIDS Awareness 2
(Date:7/21/2008)...ata from five 2008 conferences, GAITHERSBURG, Md....rivately held company developing gene therapies fo... on the VRX496 Phase I and Phase II,clinical trial...ity. VRX496,is an investigational gene therapy for... place on Thursday, July 24, 2008 at 11 a.m. EDT. ...
(Date:7/21/2008)... a Must for Clinical Trials Management, WASHINGTO...ion of,Academic Health Centers (AAHC) today launch...signed to assist academic health center leaders,r...ers in establishing,strengthening, and improving ... enterprise, particularly to manage and support co...
(Date:7/21/2008)...d limited launch in Italy continue, FRANKLIN, Mas...Inc.,(Amex: PLC ) announced today that it will de...its RenalGuard(TM) System in the prevention of,Con...nues to support the,investigator-sponsored clinica... limited market launch of RenalGuard in Europe, wh...
(Date:7/21/2008)...- Alfacell Corporation,(Nas...d in Molecular Cancer,Therapeutics (2008; 7(7):187...rnase) and the thiazolidinedione antidiabetic drug...s with increased expression of,PI3K-dependent Fra-...t of NIH-funded in vitro research conducted at,the...
Breaking Medicine Technology:VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 2VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 3VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 4VIRxSYS to Host a Web Conference to Announce Clinical Trial Update 5New AAHC Toolkit Available to Optimize Clinical Research Administration 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 2PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 3PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 4PLC Systems Defers Pivotal Study of RenalGuard(TM) in the U.S. 5Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines 2Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo 28TM 29 to Reduce Pain Associated With Needle Insertion Procedures in Adul 3808 1Anesiva Announces Submission of Supplemental New Drug Application for Zingo 28TM 29 to Reduce Pain Associated With Needle Insertion Procedures in Adul 3808 2Anesiva Announces Submission of Supplemental New Drug Application for Zingo 28TM 29 to Reduce Pain Associated With Needle Insertion Procedures in Adul 3808 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo 28TM 29 to Reduce Pain Associated With Needle Insertion Procedures in Adul 3808 4Wyeth to Invest 24280 Million to Build State of the Art Nutritional Manufacturing Facility in China 13848 1Wyeth to Invest 24280 Million to Build State of the Art Nutritional Manufacturing Facility in China 13848 2Wyeth to Invest 24280 Million to Build State of the Art Nutritional Manufacturing Facility in China 13848 3Laborie Medical Technologies Receives FDA Pre Market Clearance for TETRA 28TM 29 NIRS Accessory for the US Market 13846 1Laborie Medical Technologies Receives FDA Pre Market Clearance for TETRA 28TM 29 NIRS Accessory for the US Market 13846 2Therap Services Welcomes Anna Keith to the US Customer Support Team 13843 1Therap Services Welcomes Anna Keith to the US Customer Support Team 13843 2
..., April 26, 2007,/PRNewswire-FirstCall/ - Angiotec...aceutical and medical device company, announced th...al examining the,Vascular Wrap(TM) Paclitaxel-Elut...oday at a scientific forum in Europe. The,two-year...cular,Wrap(TM) for use in arterial bypass surgery ...
...7 /PRNewswire-FirstCall/ --,Australian drug develo...liminary results from its randomised Phase II clin...cancer, where,Alchemia,s drug HyCAMP(TM) was compa...erstone drug for the treatment of colorectal,cance...y stage of,the analysis in accordance with the ASX...
Other Medicine Technology:Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 2Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 3Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 4Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 5Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 6Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium 7Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 2Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 3Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 4Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 5Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 6Alchemia Reports Preliminary Positive Efficacy Data From HyCAMP,Phase II Trial 7
Used for endobronchial blockade of the left or right lung for procedures which require one-lung ventilation. The set consists of an endobronchial blocker catheter and an Arndt Multiport Airway Adapte
The Pedia-Trake® is designed to reduce the possibility of over penetration., ,Pedia-Trake® is used to establish an emergency airway in pediatric patients more than one year old.
...yrotomy device, you can establish an airway (up to...cothyrotomy kit is used for fast and safe emergenc...a 4.5, 6.0 and a 7.2 mm I.D. airway within seconds...te ventilation. A suction catheter can be introduc...
...o establish emergency airway access through the cr...ludes a 12 gauge x 3" Angiocath I.V. catheter, whi...ock to ventilate. Designed to be used with the lit.... Similar to the Cook Emergency Cricothyrotomy Kit...
Medicine Products: